Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.41
(-1.22%)
HKD 0.41
(-1.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -52.04 Million CNY | -158.24% |
| 2022 | 89.37 Million CNY | 333.03% |
| 2021 | -38.35 Million CNY | -325.61% |
| 2020 | 16.99 Million CNY | -72.94% |
| 2019 | 62.81 Million CNY | 13.27% |
| 2018 | 55.45 Million CNY | 4464.12% |
| 2017 | 1.21 Million CNY | -96.47% |
| 2016 | 34.43 Million CNY | -31.56% |
| 2015 | 50.32 Million CNY | 11.66% |
| 2014 | 45.06 Million CNY | -49.11% |
| 2013 | 88.56 Million CNY | 28.24% |
| 2012 | 69.06 Million CNY | 26.8% |
| 2011 | 54.46 Million CNY | -34.41% |
| 2010 | 83.02 Million CNY | 56.59% |
| 2009 | 53.02 Million CNY | -8.76% |
| 2008 | 58.11 Million CNY | 15.34% |
| 2007 | 50.38 Million CNY | -36.77% |
| 2006 | 79.68 Million CNY | 79.37% |
| 2005 | 44.42 Million CNY | -22.25% |
| 2004 | 57.13 Million CNY | 36.68% |
| 2003 | 41.8 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.28 Million CNY | 0.0% |
| 2024 Q1 | -7.28 Million CNY | 76.02% |
| 2023 Q4 | -30.38 Million CNY | -524.86% |
| 2023 FY | -52.04 Million CNY | -158.24% |
| 2023 Q1 | 3.65 Million CNY | -85.13% |
| 2023 Q2 | 3.65 Million CNY | 0.0% |
| 2023 Q3 | 7.15 Million CNY | 95.62% |
| 2022 FY | 89.37 Million CNY | 333.03% |
| 2022 Q3 | 24.58 Million CNY | 4.22% |
| 2022 Q4 | 24.58 Million CNY | 0.0% |
| 2022 Q1 | 23.59 Million CNY | 347.4% |
| 2022 Q2 | 23.59 Million CNY | 0.0% |
| 2021 Q4 | -9.53 Million CNY | 0.0% |
| 2021 Q1 | -865 Thousand CNY | -624.24% |
| 2021 Q2 | -865 Thousand CNY | 0.0% |
| 2021 Q3 | -9.53 Million CNY | -1002.31% |
| 2021 FY | -38.35 Million CNY | -325.61% |
| 2020 Q3 | 165 Thousand CNY | -98.39% |
| 2020 Q4 | 165 Thousand CNY | 0.0% |
| 2020 Q1 | 10.24 Million CNY | 33.92% |
| 2020 FY | 16.99 Million CNY | -72.94% |
| 2020 Q2 | 10.24 Million CNY | 0.0% |
| 2019 Q4 | 7.64 Million CNY | 0.0% |
| 2019 Q2 | 24.11 Million CNY | 0.0% |
| 2019 Q1 | 24.11 Million CNY | 26.32% |
| 2019 Q3 | 7.64 Million CNY | -68.29% |
| 2019 FY | 62.81 Million CNY | 13.27% |
| 2018 Q2 | 8.41 Million CNY | 0.0% |
| 2018 FY | 55.45 Million CNY | 4464.12% |
| 2018 Q4 | 19.09 Million CNY | 0.0% |
| 2018 Q3 | 19.09 Million CNY | 126.84% |
| 2018 Q1 | 8.41 Million CNY | 577.02% |
| 2017 Q2 | 1.61 Million CNY | 0.0% |
| 2017 FY | 1.21 Million CNY | -96.47% |
| 2017 Q4 | -1.76 Million CNY | 0.0% |
| 2017 Q3 | -1.76 Million CNY | -209.12% |
| 2017 Q1 | 1.61 Million CNY | -38.45% |
| 2016 Q4 | 2.62 Million CNY | 0.0% |
| 2016 Q2 | 11.97 Million CNY | 0.0% |
| 2016 Q3 | 2.62 Million CNY | -78.06% |
| 2016 Q1 | 11.97 Million CNY | -14.94% |
| 2016 FY | 34.43 Million CNY | -31.56% |
| 2015 FY | 50.32 Million CNY | 11.66% |
| 2015 Q3 | 14.07 Million CNY | 89.78% |
| 2015 Q4 | 14.07 Million CNY | 0.0% |
| 2015 Q1 | 7.41 Million CNY | -36.15% |
| 2015 Q2 | 7.41 Million CNY | 0.0% |
| 2014 Q2 | 10.94 Million CNY | 0.0% |
| 2014 Q1 | 10.94 Million CNY | -53.55% |
| 2014 FY | 45.06 Million CNY | -49.11% |
| 2014 Q4 | 11.61 Million CNY | 0.0% |
| 2014 Q3 | 11.61 Million CNY | 6.17% |
| 2013 Q2 | 21.74 Million CNY | 31.15% |
| 2013 FY | 88.56 Million CNY | 28.24% |
| 2013 Q4 | 23.55 Million CNY | 0.0% |
| 2013 Q3 | 23.55 Million CNY | 8.3% |
| 2013 Q1 | 16.58 Million CNY | 10.35% |
| 2012 Q3 | 19.74 Million CNY | -24.91% |
| 2012 FY | 69.06 Million CNY | 26.8% |
| 2012 Q4 | 15.02 Million CNY | -23.91% |
| 2012 Q2 | 26.29 Million CNY | 229.1% |
| 2012 Q1 | 7.99 Million CNY | -25.65% |
| 2011 FY | 54.46 Million CNY | -34.41% |
| 2011 Q3 | 13.55 Million CNY | -24.86% |
| 2011 Q1 | 12.11 Million CNY | -64.06% |
| 2011 Q2 | 18.04 Million CNY | 48.94% |
| 2011 Q4 | 10.74 Million CNY | -20.72% |
| 2010 Q3 | 18.7 Million CNY | -1.69% |
| 2010 Q4 | 33.7 Million CNY | 80.18% |
| 2010 FY | 83.02 Million CNY | 56.59% |
| 2010 Q2 | 19.02 Million CNY | 0.0% |
| 2009 FY | 53.02 Million CNY | -8.76% |
| 2009 Q2 | 15.24 Million CNY | 0.0% |
| 2008 FY | 58.11 Million CNY | 15.34% |
| 2007 FY | 50.38 Million CNY | -36.77% |
| 2006 FY | 79.68 Million CNY | 79.37% |
| 2005 FY | 44.42 Million CNY | -22.25% |
| 2004 FY | 57.13 Million CNY | 36.68% |
| 2003 FY | 41.8 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 14.89 Million HKD | 449.48% |
| Lee & Man Chemical Company Limited | 473.28 Million HKD | 110.997% |